Immunocore Holdings plc
IMCR Nasdaq
SEC CIK 1671927
Follow Immunocore
Weekly email: filings, results
Revenue, last quarter
$102.2M
−1.4% vs same quarter last year
Net income
−$14.2M
−7935% vs same quarter last year
EPS, diluted
−$0.28
Operating cash flow
$20.1M
+550.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $400M | −$35.5M |
| FY24 | $310.2M | −$51.1M |
| FY23 | $249.4M | −$55.3M |
| FY22 | $174.4M | −$52.5M |
| FY21 | $4.1M | −$180M |
| FY20 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 98.7% | −11.3% | −8.9% |
| FY24 | 99.1% | −22.7% | −16.5% |
| FY23 | 99.6% | −23.9% | −22.2% |
| FY22 | 99.4% | −29.7% | −30.1% |
| FY21 | 100% | −4281.2% | −4414.6% |
| FY20 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$15.1M |
| FY24 | $20.9M |
| FY23 | −$2.5M |
| FY22 | −$51.4M |
| FY21 | −$144.5M |
| FY20 | - |
- Immunocore
- Healthcare median
Show the numbers
| Year | Immunocore | Healthcare median |
|---|---|---|
| FY25 | −8.9% | −30.6% |
| FY24 | −16.5% | −47% |
| FY23 | −22.2% | −58% |
| FY22 | −30.1% | −80.4% |
| FY21 | −4414.6% | −71.9% |
| FY20 | - | −62.2% |